{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Kennett Square",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97202",
      "recalling_firm": "Boothwyn Pharmacy LLC",
      "address_1": "221 Gale Ln",
      "address_2": "N/A",
      "postal_code": "19348",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-0608-2025",
      "product_description": "Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy",
      "product_quantity": "186 vials",
      "reason_for_recall": "Subpotent Drug",
      "recall_initiation_date": "20250709",
      "center_classification_date": "20250829",
      "report_date": "20250910",
      "code_info": "03202025@9 BUD 07/18/2025"
    }
  ]
}